Rhythm Pharmaceuticals Inc. · 4 hours ago
Senior Manager, Business Analytics & Reporting
Boston, MA
Full-time
Hybrid
Senior Level
$135K/yr - $215K/yr
6+ years expRhythm Pharmaceuticals Inc. is a global biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases. The Senior Manager, Business Analytics & Reporting will act as an analytics partner for various North America Region teams, translating complex business queries into actionable insights and managing competing priorities to deliver high-quality work products.
BiotechnologyPharmaceuticalTherapeutics
Responsibilities
Serve as an analytics bridge between teams—translating urgent business questions into rigorous, actionable analyses
Manage competing stakeholder priorities, set realistic expectations, and deliver insights that shape daily decisions and quarterly strategy
Build credibility by explaining what the data can and cannot answer, educating teams on methodology, and maintaining transparency about trade-offs
Uncover the 'why' behind performance trends
Own recurring metrics that matter: Rx volume, patient flow, reimbursement approval rates, demand shipments, channel mix
Support executive presentations for earnings calls, board meetings, and investor events—distilling complex analyses into clear visuals with actionable takeaways
Write efficient SQL queries against Snowflake databases (claims, pharmacy feeds, CRM data) to extract and harmonize large commercial and patient datasets
Design and automate Power BI dashboards that give real-time visibility into performance
Use Python for exploratory analysis—testing hypotheses, identifying opportunities and risks, automating repetitive reporting
Document your work and champion best practices in data quality, version control, and peer review
Qualification
Required
Bachelor's degree in Business Analytics, Statistics, Computer/Data Science, or related field (advanced degree preferred)
6+ years in pharma/healthcare analytics or BI, ideally with exposure to specialty pharmacy data, reimbursement dynamics, and rare-disease commercialization
Experience working with large healthcare datasets such as claims, pharmacy adjudication feeds, or EMR data to understand patient journeys and real-world treatment patterns
Advanced SQL proficiency (complex joins, window functions, query optimization)
Expert-level Power BI or Tableau skills for dashboard development
Strong Python capabilities for data wrangling and exploratory analysis (pandas, NumPy, scikit-learn, Plotly/Matplotlib)
Comfort leveraging AI tools (e.g., ChatGPT, Claude, Copilot) to accelerate workflows—using LLMs for hypothesis generation, code review, documentation, and scenario testing while maintaining critical judgment on outputs
Track record of managing multiple high-priority projects in fast-paced launch environments
Ability to build trust with senior stakeholders, diplomatically negotiate priorities, and deliver difficult messages when needed
Benefits
A discretionary annual bonus may be available based on individual and company performance.
This role may be eligible for benefits and other compensation such as restricted stock units.
Company
Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals is a global, commercial-stage biopharmaceutical company focused on transforming the lives of patients with rare neuroendocrine diseases by rapidly advancing care and precision medicines that address the root cause.
201-500 employees
H1B Sponsorship
Rhythm Pharmaceuticals Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (1)
2023 (1)
2022 (4)
Funding
Current Stage
Public CompanyTotal Funding
$1.22BKey Investors
HealthCare Royalty PartnersMPM Capital,New Enterprise Associates
2025-07-10Post Ipo Equity· $175M
2024-04-01Post Ipo Debt· $150M
2022-09-14Post Ipo Equity· $124.8M
Leadership Team
Elisabeth Crönert-Bendell
SVP, Head of Strategy
Recent News
The Motley Fool
2026-02-02
2026-01-20
2026-01-11
Company data provided by crunchbase